Global Targeted Drugs for Colorectal Cancer Market Growth 2025-2031
Description
The global Targeted Drugs for Colorectal Cancer market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Targeted Drugs for Colorectal Cancer Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Colorectal Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Colorectal Cancer sales for 2025 through 2031. With Targeted Drugs for Colorectal Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Colorectal Cancer industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Colorectal Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drugs for Colorectal Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Colorectal Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Colorectal Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Colorectal Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Colorectal Cancer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
EGFR Target
BRAF Target
MEK1/2 Targets
BRAF V600 Target
HER2 Target
VEGFR-1/2/3 Targets
PD-1 Target
CTLA-4 Target
Segmentation by Application:
Hospital
Specialty Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Amgen
F. Hoffmann-La Roche Ltd
Novartis
Array BioPharma
Genentech
Bayer
Sanofi
Lilly
Bristol myers squibb
MSD lreland
HUTCHMED
Key Questions Addressed in this Report
What is the 10-year outlook for the global Targeted Drugs for Colorectal Cancer market?
What factors are driving Targeted Drugs for Colorectal Cancer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Drugs for Colorectal Cancer market opportunities vary by end market size?
How does Targeted Drugs for Colorectal Cancer break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Targeted Drugs for Colorectal Cancer Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Colorectal Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Colorectal Cancer sales for 2025 through 2031. With Targeted Drugs for Colorectal Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Colorectal Cancer industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Colorectal Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drugs for Colorectal Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Colorectal Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Colorectal Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Colorectal Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Colorectal Cancer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
EGFR Target
BRAF Target
MEK1/2 Targets
BRAF V600 Target
HER2 Target
VEGFR-1/2/3 Targets
PD-1 Target
CTLA-4 Target
Segmentation by Application:
Hospital
Specialty Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Amgen
F. Hoffmann-La Roche Ltd
Novartis
Array BioPharma
Genentech
Bayer
Sanofi
Lilly
Bristol myers squibb
MSD lreland
HUTCHMED
Key Questions Addressed in this Report
What is the 10-year outlook for the global Targeted Drugs for Colorectal Cancer market?
What factors are driving Targeted Drugs for Colorectal Cancer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Drugs for Colorectal Cancer market opportunities vary by end market size?
How does Targeted Drugs for Colorectal Cancer break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
111 Pages
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Targeted Drugs for Colorectal Cancer by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Targeted Drugs for Colorectal Cancer by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
